Covered recipient · General Payments record
GLORIA LUCILLE HARDEN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,258.23
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $436.25 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $148.45 | 9 |
| Novo Nordisk AS | $76.29 | 4 |
| Amgen Inc. | $68.35 | 4 |
| Acerta Pharma LLC | $37.31 | 2 |
| Astellas Pharma US Inc | $31.09 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.15 | 1 |
| ABBVIE INC. | $20.78 | 1 |
| SANOFI-AVENTIS U.S. LLC | $16.37 | 1 |
| Corcept Therapeutics | $14.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.78 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107287498 | CMS |
| Amgen Inc. | $15.63 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117572941 | CMS |
| Amgen Inc. | $14.01 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117572943 | CMS |
| Amgen Inc. | $24.85 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115701712 | CMS |
| Amgen Inc. | $13.86 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117572945 | CMS |
| Astellas Pharma US Inc | $16.01 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139487208 | CMS |
| Astellas Pharma US Inc | $15.08 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520371 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.34 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104418555 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.97 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104446053 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $23.15 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117951790 | CMS |
| Corcept Therapeutics | $14.46 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117789737 | CMS |
| Lilly USA, LLC | $16.66 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135683969 | CMS |
| Lilly USA, LLC | $15.49 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135675314 | CMS |
| Lilly USA, LLC | $18.94 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135675316 | CMS |
| Lilly USA, LLC | $18.49 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135675318 | CMS |
| Lilly USA, LLC | $10.32 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135651485 | CMS |
| Lilly USA, LLC | $17.17 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135672186 | CMS |
| Lilly USA, LLC | $12.43 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135639582 | CMS |
| Lilly USA, LLC | $14.48 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135672188 | CMS |
| Lilly USA, LLC | $24.47 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135672184 | CMS |
| Novo Nordisk Inc | $19.42 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100490609 | CMS |
| Novo Nordisk Inc | $14.25 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100366951 | CMS |
| Novo Nordisk Inc | $21.94 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100478132 | CMS |
| Novo Nordisk Inc | $20.68 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100454496 | CMS |
| SANOFI-AVENTIS U.S. LLC | $16.37 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139884538 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.